A Study to Evaluate the Efficacy and Safety of Abiprubart in Participants With Sjögren's Disease
Trial details
- Registry ID
- NCT06531395
- Phase
- Phase 2
Drug identity checked against registry records
Also recorded as KPL-404
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| A Study to Evaluate the Efficacy and Safety of Abiprubart in Participants With Sjögren's DiseaseNCT06531395 | KNSA | Phase 2 | Terminated | 2025-03-06Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |